Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line - PubMed (original) (raw)

Affiliations

PMID: 1705688

Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line

P Laneuville et al. Oncogene. 1991 Feb.

Abstract

We have studied the effect of a replication-defective murine retroviral vector expressing the chronic myelogenous leukemia associated oncoprotein p210bcr/abl in murine IL-3 dependent myeloid 32D C13(G) cells. This cell line can be induced to differentiate along either the granulocytic or monocytic lineages thus permitting an independent assessment of the effect of p210bcr/abl on growth and differentiation. Cells expressing p210bcr/abl displayed a complete non-autocrine abrogation of IL-3 dependence and an enhanced response to an activity in FBS which is not IGF-I or IGF-II. During the first few generations following infection with the bcr/abl vector, cells became larger with an increased fraction of cells in G2/M and monocyte/macrophage markers were expressed. Four cytoplasmic proteins phosphorylated in response to IL-3 in the parental cell line with apparent molecular weights of 98, 70, 62, and 52 Kd were amongst those constitutively phosphorylated in p210bcr/abl expressing cells. These results suggest that the functional substitution of IL-3 by p210bcr/abl is due to constitutive activation of proteins involved in IL-3 signal transduction. Alterations of cell differentiation, cell cycle and growth which cannot be attributed to IL-3 like effects indicate that p210bcr/abl has pleiotropic effects involving several other pathways of cellular regulation.

PubMed Disclaimer

Cited by

Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene.
Zafriri D, Argaman M, Canaani E, Kimchi A. Zafriri D, et al. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):477-81. doi: 10.1073/pnas.90.2.477. Proc Natl Acad Sci U S A. 1993. PMID: 8421678 Free PMC article.
Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL.
Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD. Matsuguchi T, et al. EMBO J. 1995 Jan 16;14(2):257-65. doi: 10.1002/j.1460-2075.1995.tb06999.x. EMBO J. 1995. PMID: 7530656 Free PMC article.
Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
Senechal K, Heaney C, Druker B, Sawyers CL. Senechal K, et al. Mol Cell Biol. 1998 Sep;18(9):5082-90. doi: 10.1128/MCB.18.9.5082. Mol Cell Biol. 1998. PMID: 9710592 Free PMC article.
Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.
Kuribara R, Honda H, Matsui H, Shinjyo T, Inukai T, Sugita K, Nakazawa S, Hirai H, Ozawa K, Inaba T. Kuribara R, et al. Mol Cell Biol. 2004 Jul;24(14):6172-83. doi: 10.1128/MCB.24.14.6172-6183.2004. Mol Cell Biol. 2004. PMID: 15226421 Free PMC article.
Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.
Chaturvedi P, Sharma S, Reddy EP. Chaturvedi P, et al. Mol Cell Biol. 1997 Jun;17(6):3295-304. doi: 10.1128/MCB.17.6.3295. Mol Cell Biol. 1997. PMID: 9154828 Free PMC article.

Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line - PubMed (original) (raw)